BD dives on Q1 profit slide, lowered guidance

Becton, Dickinson & Co.

Shares of Becton, Dickinson & Co. (NYSE:BDX) continued their slide today after closing down yesterday following the release of the medical products giant’s fiscal 1st quarter results.

Investors, reacting to a lower forecast for the rest of the year and to a nearly 17% profit slide, sent shares down to $77.51 last night, a 3.8% decline. Shares were trading at $76.89 as of about 12:50 p.m. today, down 0.8%.

Becton, Dickinson posted profits of $263.0 million, or $1.21 per diluted share, on sales of $1.89 billion during the 3 months ended Dec. 31, 2011. That’s a top-line gain of 2.5% but a bottom-line decline fo 16.8%, compared with Q1 2011.

Excluding a 1-time tax gain of 4 cents per share, adjusted EPS was in line with analysts’ expectations at $1.21 apiece.

“We are pleased with our solid start to fiscal year 2012 given the challenging macroeconomic climate,” president & CEO Vincent Forlenza said in prepared remarks. “Our operating results reflect our increased investments in high-growth areas. We will continue to drive efficiency throughout the Company and we remain committed to delivering value to our customers and shareholders.”

CFO David Elkins told analysts on a conference call that BD now expects full-year sales growth to be flat due to a stronger dollar. The company had predicted sales growth of 1% to 3% for fiscal 2012. Earnings per share are now pegged to run between $5.60 and $5.70 for the full year, down from $5.75 to $5.85.

"While we don’t normally provide guidance for the quarter, I would like to outline our expectations for the 2nd quarter," Elkins said. "In our Medical surgical systems business, we expect growth rates to improve in the 2nd half of the year as we move past pricing comparisons.

"From an EPS perspective, we anticipate earnings per share to be between $1.36 and $1.40, or about flat versus the prior period. Second-quarter EPS growth versus the prior-year period will continue to be unfavorably impacted by tough comparisons in 2011. These tough comparisons include price erosion and increased investments in SG&A, which began in the 2nd half of fiscal year 2011 and will continue through the 2nd quarter of fiscal year 2012," he said. "We expect a step-up in EPS growth during the 2nd half of the year once we move past the difficult comparisons of 2011."

Sales for BD Medical rose by 2.3% during the quarter, driven by a 17.5% gain from its pharmaceuticals business, which added $60.7 million to the top line. Sales for BD’s medical surgical systems segment slid 2.3% to $248.4 million during the quarter; diabetes care sales rose 6.0% to $105.5 million.

Elkins said the company is expecting more from the division during the full year.

"We are raising the lower end of our medical segment guidance and expect revenues to grow between 2% and 3%," he said, noting that BD expects the pricing pressure that eroded that business during the second half of 2011 to ease during the second half of this year. "So we will see improvement in U.S. as that tough comparison goes away. And then overall, we’re seeing very good growth and increased confidence internationally on med/surg business. Those 2 factors combined is why we’re bringing up the bottom end of the range on the medical segment overall."

RSS From Medical Design & Outsourcing

  • Emuge expands solid carbide thread mill program with new 3XD sizes
    Emuge is now offering an expanded line of Solid Carbide Thread Mills in their popular THREADS-ALL Program, to include new 3XD sizes designed for maximum reach. A total of 17 new sizes have been added, from miniature to standard size tools, providing maximum versatility in a wide range of thread milling applications. The 3XD THREADS-ALL […]
  • Start of helpful humanoid robots? CITEC uses compact LDS component as sensor array
    Editor’s Note: LaserMicronics, a service provider for laser-based manufacturing, has released the whitepaper “Robot hand with a sensitive touch: LDS tactile sensors for sensorimotor skills.” The paper describes a 2014 project from the CITEC department at Bielefeld University in Bielefeld, Germany, where researchers created a tactile sensor resembling a human fingertip. The sensor was then […]
  • Nature meets technology: Festo’s BionicANTs cooperate to solve a common task
    Editor’s Note: Festo, an industrial control and automation company, has released the whitepaper “BionicANTs: Cooperative behavior based on a natural model.” The paper describes the BionicANT, a creation of Festo engineers that duplicates the physical anatomy of its natural counterpart and reproduces the insect’s cooperative behavior. Festo engineers have used the delicate anatomy of an […]
  • Acorn Regulatory streamlines approval process drug-device manufacturers
    Acorn Regulatory, an ISO-certified medical device and pharmaceutical consulting firm, is streamlining procedures for U.S. manufacturers of drug-device combinations with customized programs that successfully overcome challenges in meeting European regulatory approvals. Focusing on small to mid-size companies, Acorn Regulatory has put in place a comprehensive step-by-step process that provides the correct regulatory pathway for medical […]
  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]

Leave a Reply